Physician profile
Ryan S Williams
NPI 1760664072
$4,391.74
in general payments reported to CMS, 2019-2025
30 companies · $632 in 2025
The $632 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953 · 2020: $266 · 2021: $242 · 2022: $661 · 2023: $637 · 2024: $1,001 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,269.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $592.21 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $531.02 | 2019-2025 | Gallant, Jot Dx, Assurity |
| Novartis Pharmaceuticals Corporation | $423.58 | 2019-2025 | |
| Pfizer INC. | $415.33 | 2019-2025 | |
| Boston Scientific Corporation | $329.33 | 2019-2025 | Watchman Access System, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $254.87 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $238.09 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $222.90 | 2019-2025 | Camzyos |
| Astellas Pharma US INC | $214.65 | 2019 | |
| Biotronik INC. | $157.54 | 2019-2024 | Biomonitor, Rivacor 7 Dr-T, Renamic Neo |
| Merck Sharp & Dohme LLC | $125.22 | 2022-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $111.35 | 2019-2024 | Xarelto |
| Amgen INC. | $95.51 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.86 | 2019-2024 | Jardiance |
| Biosense Webster, INC. | $86.78 | 2025 | Carto 3, Smartablatetm System Rf Generator |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $78.32 | 2020 | |
| Bardy Diagnostics, INC. | $46.97 | 2019-2021 | |
| Esperion Therapeutics, INC. | $41.42 | 2021-2023 | Nexletol |
| Scpharmaceuticals INC. | $39.86 | 2025 | |
| Cardiva Medical, INC. | $37.17 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amarin Pharma, INC. | $36.38 | 2019 | |
| Smith+Nephew, INC. | $34.61 | 2024 | Bone Anchors With Arthroscopic Delivery System |
| Itamar Medical INC | $31.48 | 2023 | Watchpatone |
| Elutia, INC. | $26.65 | 2019 | |
| Allergan, INC. | $26.59 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.26 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $21.03 | 2024 | Arcalyst |
| Azurity Pharmaceuticals, INC. | $20.41 | 2024 | Edarbyclor |
| Heartflow, INC. | $18.67 | 2024 | |
| Baxter Healthcare | $16.68 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.